Reuters
@Reuters·4.2M subscribers·86.9K videos
FDA narrows patient group for Biogen's Alzheimer's drug
Posted
July 8, 2021
Views
626
Likes
15
Engagement
2.40%
July 8, 2021
626
15
2.40%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:17Now PlayingBiogen said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer's disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.
#Biogen #Alzheimer #Aduhelm #FDA #News #Reuters
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
